Andrea Tan
Stock Analyst at Goldman Sachs
(1.48)
# 3,503
Out of 5,017 analysts
47
Total ratings
40.54%
Success rate
-9.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Buy | $121 → $196 | $163.94 | +19.56% | 12 | Oct 3, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.14 | +273.83% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $70.34 | -27.50% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $7.19 | +275.52% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $7.60 | -21.05% | 5 | Jul 1, 2024 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Neutral | $31 | $36.25 | -14.48% | 1 | Jun 5, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $2.02 | -0.99% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $11.60 | -82.76% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $184.74 | -13.39% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $5.67 | +323.28% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.39 | +187.77% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $427.73 | -12.33% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $32.29 | +147.75% | 2 | May 24, 2022 |
Insmed
Oct 3, 2025
Maintains: Buy
Price Target: $121 → $196
Current: $163.94
Upside: +19.56%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.14
Upside: +273.83%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $70.34
Upside: -27.50%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $7.19
Upside: +275.52%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $7.60
Upside: -21.05%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $36.25
Upside: -14.48%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $2.02
Upside: -0.99%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $11.60
Upside: -82.76%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $184.74
Upside: -13.39%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $5.67
Upside: +323.28%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.39
Upside: +187.77%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $427.73
Upside: -12.33%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $32.29
Upside: +147.75%